10.1002/pds.3687 46 RosenstockJ.AllisonD.BirkenfeldA
Reconstituting and self-administering injectable compounds carries inherent risks including infection, contamination, and dosing errors
However, for certain services like blood work or hormone optimization, we can provide documentation for you to submit to insurance if appropriate
Semaglutide is particularly beneficial for patients with difficulty achieving blood sugar control through other means and those who may also benefit from weight loss as part of their diabetes management
Medical Disclaimer This information is provided for general educational purposes and does not replace medical advice, diagnosis or treatment
Eli Lilly & Co., which makes Mounjaro and Zepbound, and Novo Nordisk A/S, which makes Ozempic and Wegovy, oppose the use of their products for cosmetic weight loss